Association of Left Anterior Descending Coronary Artery Radiation Dose With Major Adverse Cardiac Events and Mortality in Patients With Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Association of Left Anterior Descending Coronary Artery Radiation Dose With Major Adverse Cardiac Events and Mortality in Patients With Non–Small Cell Lung Cancer

Published:2021-02-01 Issue:2 Volume:7 Page:206
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Atkins Katelyn M.¹²,Chaunzwa Tafadzwa L.²,Lamba Nayan²,Bitterman Danielle S.²,Rawal Bhupendra³,Bredfeldt Jeremy²,Williams Christopher L.²,Kozono David E.²,Baldini Elizabeth H.²,Nohria Anju⁴,Hoffmann Udo⁵,Aerts Hugo J. W. L.²⁶,Mak Raymond H.²

Affiliation:

1. Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California

2. Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Boston, Massachusetts

3. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts

4. Department of Cardiovascular Medicine, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Boston, Massachusetts

5. Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston

6. Department of Radiology, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2773837/jamaoncology_atkins_2020_oi_200095_1613590884.03311.pdf

Reference46 articles.

1. Cardiac toxicity and radiation dose to the heart in definitive treated non–small cell lung cancer.;Schytte;Acta Oncol,2010

2. Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non–small-cell lung cancer.;Hardy;Ann Oncol,2010

3. Cardiac toxicity after radiotherapy for stage III non–small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy.;Wang;J Clin Oncol,2017

4. Cardiac events after radiation therapy: combined analysis of prospective multicenter trials for locally advanced non–small-cell lung cancer.;Dess;J Clin Oncol,2017

5. Cardiac radiation dose, cardiac disease, and mortality in patients with lung cancer.;Atkins;J Am Coll Cardiol,2019

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating the risk of major adverse cardiac events following radiotherapy for left breast cancer using a modified generalized Lyman normal-tissue complication probability model;The Breast;2024-10

2. Cardiac Substructure Dose and Survival in Stereotactic Radiotherapy for Lung Cancer: Results of the Multi-Centre SSBROC Trial;Clinical Oncology;2024-10

3. Moving beyond mean heart dose: The importance of cardiac substructures in radiation therapy toxicity;Journal of Medical Imaging and Radiation Oncology;2024-09-03

4. Treatment of unresectable stage III non-small cell lung cancer for patients who are under-represented in clinical trials;Cancer Treatment Reviews;2024-09

5. Getting to the heart of the matter;Journal of Medical Imaging and Radiation Oncology;2024-08-29